Products
CHPF N-Terminal antibody
- Product Name
- CHPF N-Terminal antibody
- Catalogue No.
- FNab01671
- Size
- 100μg
- Form
- liquid
- Purification
- Immunogen affinity purified
- Purity
- ≥95% as determined by SDS-PAGE
- Clonality
- polyclonal
- Isotype
- IgG
- Storage
- PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
- Immunogen
- chondroitin polymerizing factor
- Alternative Names
- Chondroitin sulfate synthase 2|Chondroitin glucuronyltransferase 2|Chondroitin-polymerizing factor (ChPF)|Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II|N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II|N-acetylgalactosaminyltransferase 2|CHPF|CSS2 antibody
- UniProt ID
- Q8IZ52
- Observed MW
- 85 kDa
Application
- Tested Applications
- ELISA, WB, IHC
- Recommended dilution
- WB: 1:500-1:2000; IHC: 1:20-1:200
Validated Images
human placenta tissue were subjected to SDS PAGE followed by western blot with FNab01671(CHPF antibody) at dilution of 1:1000
Immunohistochemistry of paraffin-embedded human colon cancer tissue slide using FNab01671(CHPF Antibody) at dilution of 1:50
- Background
- Has both beta-1,3-glucuronic acid and beta-1,4-N-acetylgalactosamine transferase activity. Transfers glucuronic acid(GlcUA) from UDP-GlcUA and N-acetylgalactosamine(GalNAc) from UDP-GalNAc to the non-reducing end of the elongating chondroitin polymer. Isoform 2 may facilitate PARK2 transport into the mitochondria. In collaboration with PARK2, isoform 2 may enhance cell viability and protect cells from oxidative stress.
